Drug Information

Updated On: 18-11-2024

Home

About Us

FAQs

Feedback

Disclaimer

Site Map

Home > Search > > Drug Information

Cefotaxime - Cephalosporins- @ Third generation- (FDC-List) (Dec 2003)

Drug Name:
Cefotaxime - Cephalosporins- @ Third generation- (FDC-List) (Dec 2003)

List Of Brands:

OMNATAX INJ
TAXIM INJ

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Other Information

Patient Information

Pharmacology/ Pharmacokinetics

Interaction with Food

Pregnancy and lactation

Drug Interaction:

Drugs covered:

1st generation 2nd generation 3rd generation .

Cephalexin Cefaclor Cefixime Cefadroxil Cefamandole Cefoperazone Cephadrine Cefotoxitin Cefotaxime Cephalothin Cefuroxime Ceftizoxime Cephapirin Cefonicid Ceftriaxone Cefazolin Cefmetazole Ceftazidime Cefotetan Ceftibuten Cefprozil Cefepime Cefpodoxime Loracarbef

Refer Cephalosporins

Activity may be enhanced by aminoglcosides(Gentamicin,Tobramycin).

Indication:

U.S.FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08

Drug name Indication Date of Approval

149. Cefotaxime sodium 24-06-08

+ Sulbactam sodium for injection

(Addl.Indication)

For the treatment of lower respiratory tract infection

in children

U.S FDA APPROVED DRUGS DURING 2007

70. Cefotaxim (as sodium) 0.5mg/1gm + 18-05-07

Sulbactum (as sodium) 250mg/500mg injection

(For addtl.indctn) For surgical prophylaxis (addl.Indtn)

Lower respiratory tract infection, urinary tract infection, gynaecological infection, Bacteremia, spectecaemia, Skin and structure injection, Intra-abdominal infection,

Bone and joint infection CNS infection.

Drugs covered:

1st generation 2nd generation 3rd generation .

Refer Cephalosporins

A third generation drug

Approved by (DCI) Drug Controller GENERAL - India For Marketing

(Ref- IDMA Publication)

Name of Drug Indication Date of Approval

1.Cefotaxime sodium 0.5mg/1gm + 18-05-2007

Sulbactum sodium 250mg/500mg

for injection

Addl.Indication

For surgical prophylaxis

2. Cefotaxime sodium + Sulbactum 24-06-2008

sodium for injection

Addl.injection

For the treatment of lower respiratory tract infection in children

FIXED DOSE COMBINATIONS APPROVED BY DCG(I)

FROM JANUARY 1961 TILL NOVEMBER 2014

Name of Drug Indication Date of Approval

Sterile Cefotaxime sodium USP eq.to 26-12-2003

Cefotataxime 500mg/1000mg +

Sterile Sulbatum 250mg/500mg per vial injection

For the treatment of lower respiratory tract injection

and genito urinary tract infection

Adverse Reaction:

Anaphylactic reactions.

Pain at inj site. Hypersensitivity reactions.

GI disturbances, Candidadiasis,

Eosinophilla, Neutropenia, leucopenia, thrombocytopenia,

Rise in liver enzymes and blood urea.

Positive Coombs test.

Contra-Indications:

Hypersen to cephalosporins.

Severe renal dysfunction.

Special precautions:

Cross senstivity in penicillin-hypersensitive patients.

When combining aminoglycosides, renal function must be checked.

Lactation.

Dosages/ Overdosage Etc:

A third generation drug.

Indications:

Lower respiratory tract infection, urinary tract infection, gynaecological infection, Bacteremia, spectecaemia, Skin and structure injection, Intra-abdominal infection, Bone and joint infection CNS infection.

Dosage:

Administer IM or IV. 1g upto 12g daily dose divided and given at frequent intervals depending on the severity of infection.

Other Information:

For Availability/supplies

Contact -

1.Indian Drug Manufacturers Association (IDMA)

Phone- 022- 24944624/ 24974308

Fax- 022- 24950723

Email- idma@vsnl.com

Website: www.idma-assn.org

2.Bulk Drug Manufacturers Association (India)(BDMA)

Phone - 040-23703910/ 23706718

Fax- 040-23704804

Email- info@bdmai.org

Website: www.info@bdmai.org

Patient Information:

Refer cephalosporins

Pharmacology/ Pharmacokinetics:

Refer cephalosporins

Interaction with Food:

Refer cephalosporins

Pregnancy and lactation:

Refer cephalosporins

Search

Look In

Keyword

Mode

	Starts With		Contains

Quick Links

Home
About Us
FAQs
Disclaimer
Site Map

Free Mobile App

About Us

FAQs

Feedback

Disclaimer: Every effort has been made to ensure that the information provided in this Database is authentic and accurate. Commissions or omissions in the database, if any, are purely inadvertent and the site owner shall not accept any liability whatsoever for any adverse consequences of any nature arising to any individual or third party, as a result of usage of this information.